N
Google TrendCHAMPIONS LEAGUE SCHEDULE (500+) — Champions League Matchday 2: Key stats and what to look out for in every game
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:champions league schedule500+matthew stone sr500+geomagnetic storm aurora visibility northern us500+selma blair5000+al-nassr vs neftchi fergana5000+samantha busch500+crimson rescued mountain lion cub500+peggy flanagan200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Precision BioSciences Set" (30 stories)

Top Headline Story

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones
Lead StoryBusiness Wirescience
Jul 27

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones

<a href="https://news.google.com/rss/articles/CBMiowJBVV95cUxNRGgyVXl3OHd1WU9YN3YxOE1zaWFtLWFsa2dWd01WMkhxckVyMU5HUnN0eU1EOFZ4U2pndlZlTlI0TGxJUm1qZHpEdGt4OGtfWnRhM3FfWUUtU3FHYi1PWFlkLTViSE03d0puU1drcWRJUHpCcW1iWHlINThkaE1UV09zdWVoUEFOWFJUQTFhaHVCWExTeGJGejR5T3h3eWNUVXpvSmRBMUNaeURka2VnN19lMDlMRXkxUnFmWXhTVmNhclpZMmwyaVc4cHNHT3Nnb3A5TUxicXdYM2VQUDZralNINFJsUW1fZFFyc0czRFlyTjdWRXhPQmxsWnhNWGhXTFBYazd6YXFrRG55bVliSWpFQWNkYTFrY0tOSFF0NVByS1k?oc=5" target="_blank">Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+22m ago

champions league schedule

Champions League Matchday 2: Key stats and what to look out for in every game

Filter stories
500+32m ago

matthew stone sr

Victims of Pennsylvania mass shooting included pregnant daughter of gunman

Filter stories
500+32m ago

geomagnetic storm aurora visibility northern us

Northern Lights Forecast: Aurora Could Be Visible From These 10 States Monday

Filter stories
5000+52m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

Filter stories

Search Results for "Precision BioSciences Set"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Precision BioSciences stock fell 3.25 percent during biotech event
AD HOC NEWStech

Precision BioSciences stock fell 3.25 percent during biotech event

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQMjRzaFJjUnNKdzlvemxwd2RveVFZaTBLd0E4RnJzbWVwdTJoajc1Q0pxWDJKZHprWEYyTm95RDFScnIyUGc4Tjk4THhGVk93TjNRNlN1dTFuejd3WGhfaDFRcEdHbkpqTWdzRlBmVzhHWFhtQURJc2xJTUo2SmRuMnZKc0tYa0pDak1seHhZT1hqQUVBcU1wYWQ3bXJNTE9qdGRSbUgyTHM5ZjBhWFJDZ1pJRXJiU1JfWnRSaDBWUlhuU3c?oc=5" target="_blank">Precision BioSciences stock fell 3.25 percent during biotech event</a>  <font color="#6f6f6f">AD HOC NEWS</font>

Read Full StoryMore like this
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
Yahoo Financescience

Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNc3FDTW01RWNjSU5GUUpoMFZmaVplMENZUE9tUzZJa0oyajN0WG1QbVdMOGpPVEFGNUZVaGk1YmlCQUZ6MTBUUXFubnE4OFM4TnRCTVdfaExrTjI2c2tja0ViSjdWd3pVVnBJVmZyZFk5bHpLWWZVaGFsUmNLMm1lSWhXOFZ4dFV4eEZpUFhfMDQzWXExSGdHLWhJaEs1WXUyUzYwdTY5MXE?oc=5" target="_blank">Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026
BioSpacescience

Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026

<a href="https://news.google.com/rss/articles/CBMitAJBVV95cUxQOFdrQ1N3U0dZQTJEd2NPR1hoc0NFSklsNUNoS0xQcEZXOUtVamQ1bGF0S2haSEtoY3BtelkzaDBOb2U3ajcyM0labjFDMnJkaW5KTV9iNklfVmdnN09HeVBMeGdscGtWcVJKS0RyVTRyRHNtSGNuXzR5VDVYelBoMDhGMy1KQXV6V0xmSU5iY00wRkIyaWxmVVRKM0szR01zUFRBb0lycnlYOTFUTm1qdnhXemNPc1g1OFU3bmZobUZ6SWFHNTBsRE9QRGRDMnlDd2VMZEtMSDZ2T29rbllybC1UOVlXMFJPak5YOWxYODMtekZ6TnMwOXdpUnprbDRObHZMWTZOWktUQTRhSWZ4VE1qU3lTS0VZN19neHVJb3I3RXFKQ2ZwdW41bl9uN1FCLXo2Zw?oc=5" target="_blank">Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake
Stock Titanscience

Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQaklnc25ocUtydUFqbm5zQmljU01wSzViUm1xWGRwcms5Z1NXU1Z1cWFobEhDNzEyby1lS3VZc2I1WFdDc1ctSXRmNmlOZl8yQmx4bWpxWnVTYWlUVDdrZ2dBalpGaEpEcElFY2VnbHU2azR0WjkwV3FKcUZHNmgxck0zeF8xZVBVcHM0NVh0bF9rMkdxTVE1eHhvbTdqZElDeGlBaThBa2tGNThGeGpQaWlZS1hhcTRnWXBXUWZZQzdpeVlFc2NRUlNPZw?oc=5" target="_blank">Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
Business Wirescience

Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy

<a href="https://news.google.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?oc=5" target="_blank">Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight
PR Newswiremarkets

CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight

<a href="https://news.google.com/rss/articles/CBMixwJBVV95cUxPS0RROG9qRXVzeFlmQUJNcXQ4eHVLQk9tWEFhVnRqeUNkajJZS1U1V2F5UkxzWkxMYWJvYXF4Nk9WQ2xaTnBfZDBSOG4ybTVjNEM1WDJhZVVRZWExdUZCdHktbGNEbXY0V1Awa05qWVZpRjFGc0ZyemMwOF9PTkxONVRXeklDaXVDQ2RUR3gycmd5SVBIeVFhT1gyZHBjLUJpeVkyYldfaWp0N3c2TVMzallUemxKb2V5OHRlU1NXbmFBaHMtanY1T2JfelpSbFJ6ZVRvbVN6T25yMjVoVHpXUmpoeC0wcGhmSmlwSjEzb1FKbGItVEtSekhGQ1d5d0k3YWFCYVZBaDBxQURscDRwcXo1UG5DQTVrc25DUjRYdVNPRm04cXU3TkhSanowRmZmMFppZHBtUGV5MXkxbEp1OFkwWHlwZlE?oc=5" target="_blank">CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Cogent Biosciences set to report earnings ahead of FDA decisions
Investing.comscience

Cogent Biosciences set to report earnings ahead of FDA decisions

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPUGRndERvd29QOWx0NGowQ25KNm02Zmg4M3o5a1pqaVJYUVB5MDloaEs4dzRIVmU3eVNuOENKZEpsQ0hWWHFPS0lnTXFKQkhnZWxFRmFtZjdDRXIxZTlQUzkybl9ybUVTVTh4Z1YzQVpNVXlsZFdzMWxvWHFXZHR3RHZsZTRNOW92ZUhvWmlONThETUNkZFJMSUdkVkhtOUpFX28zakc3YUY3eW1BREZ6TUVDRlZzR3VF?oc=5" target="_blank">Cogent Biosciences set to report earnings ahead of FDA decisions</a>  <font color="#6f6f6f">Investing.com</font>

Read Full StoryMore like this
Yarrow Bioscience (Nasdaq:YARW) - Stock Analysis
Simply Wall Streetmarkets

Yarrow Bioscience (Nasdaq:YARW) - Stock Analysis

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPUnhnZkhma0traERPOE90Umtxbmx1ZG8yQ3BKNExjWTdTcDl6UHVFckN5Vks3U01NVkdxY1NURTA4QWdpa1NzYThxVFFQeExjZUtseFdwczZuQUc5dDJUYWh3VU10RjFYUTdmQ2V2Ty0wRlFfZk0zclpjRFlTei1QeVhhdjdlelZoQ0E4cm53?oc=5" target="_blank">Yarrow Bioscience (Nasdaq:YARW) - Stock Analysis</a>  <font color="#6f6f6f">Simply Wall Street</font>

Read Full StoryMore like this
ALMR IPO News - Protein biomarker detection platform Alamar Biosciences sets terms for $150 million IPO
Renaissance Capitalscience

ALMR IPO News - Protein biomarker detection platform Alamar Biosciences sets terms for $150 million IPO

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxQWFJzQktNMWlSYWplLWVrcF9yVmI4amhCWElxSnBIYXhwa2JNLW9HYlJWdEFNZnZkR29kc0h1aVVTX0RUZ2FxQ1RpU195cGtlYzlkamhTM01OU2otVG8zLVBXUDRqekRiWnFYcnY0alFBYzk5QXZiMjFrR1BCZ3Nhcy02eGZmaThOOWFPYjFDN1RaSlFlNlJkMDdzZE1MLVg4RUNqY1JkU0IzWHE2VUJDZ1hfeEViN1I2MDdpVF9kU283T3ZSb3RsNmx3b3k?oc=5" target="_blank">ALMR IPO News - Protein biomarker detection platform Alamar Biosciences sets terms for $150 million IPO</a>  <font color="#6f6f6f">Renaissance Capital</font>

Read Full StoryMore like this
Aura Biosciences Grants Inducement Equity Awards to New CEO Natalie Holles
Quiver Quantitativescience

Aura Biosciences Grants Inducement Equity Awards to New CEO Natalie Holles

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPcVVqMENIRWVZYzlZV3VOc0NsYmV4cld0V2JoTEtOaWw3eEV2ZGZROEotWXFYTVVydmp0UmR6bC1Xd2FjOWFDeXk3eDFwX3BvUHdzNG8xaDRxclU0d0Q2TktJS3NBNUtVa1IweEZYaWVVMThuamNuNHNJUEF0eUg2Q2UyVFJKTXNla0NtV2x3UnRJdzZUOXoteElVS1VYcHN2U3RlOFNsQWhOMVk?oc=5" target="_blank">Aura Biosciences Grants Inducement Equity Awards to New CEO Natalie Holles</a>  <font color="#6f6f6f">Quiver Quantitative</font>

Read Full StoryMore like this
Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants
Latham & Watkins LLPmarkets

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNdGItcU1lU2lmbGZSNVNsTUk1UWkzVThja2tzOHRYajRjT2NvN0VIZUtVRWM5Vk5yaVhPeElUbEc3MV9Nd0w4Y1QxN0ZqYnA3RWYwbHR5d3lpVXhBR1ZERHl5MkNhS29CRkdaUUJibjZVbV9hLWJmQTVVamhGWW9QVy02WkkzTmhocGJKQTlxSVlYblNERjAtcy1Sd3pXR1BpcEpzQkVHWV9QUDh0NjYydGo3Vlp4THU1cmhHLXB5QUNOa3lKZ0F2YnhFYjU?oc=5" target="_blank">Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants</a>  <font color="#6f6f6f">Latham & Watkins LLP</font>

Read Full StoryMore like this
Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Smart Beta Flow
https://www.dars.gov.et/tech

Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Smart Beta Flow

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNdUFra1FwM3E5R2VmUVJLZzlKTVdrNERRZHEyQzV4bXg0OXdGa1lUeXUxYU91cmhfOFNJSU1rQS1YT3BubUpRdTR1T01VN01RSmJETC1nVzc4LURRWTAzRExiS1RKYWNNNUNma3pfUlI5WEFFZ3BIV3F1T2d0VkFzQkxVanA4dTFjbHh5TVFUVkhweGxOTUViaTZscjFWWC1JZnV0THFzNXpNRGx5TnRlTVRPeWg5UUh6OGlVRDJ0V2Z0UUE?oc=5" target="_blank">Precision BioSciences (DTIL) Rallies 3.5% as Biotech Stock Tests Key Resistance Level - Smart Beta Flow</a>  <font color="#6f6f6f">https://www.dars.gov.et/</font>

Read Full StoryMore like this
TG Therapeutics to Discuss 2026 Outlook on Aug. 3 Call
Stock Titangeneral

TG Therapeutics to Discuss 2026 Outlook on Aug. 3 Call

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQWVB1cGEzemFVUDZMNGgwSWRtX1FXc2VUMHFoWWNhMlBUdmNsM1hNdi1TS0ZkYXRDbTUxMHhjWnBRU1h0TlZGZnA0V2dxVFotUFp6SFd0N2lxWFlmeU1IQy1sNEpibU9Xc2lSeTVKTk15TzBwZ3pSaTVoUzdlTEZ3ZExPWnhvV25xWG5GM25HYVJYV1BnQzFyUGJRR01YTjJKN0tibVhMLXVSZG5OYnFsbkl5S2w5dkZB?oc=5" target="_blank">TG Therapeutics to Discuss 2026 Outlook on Aug. 3 Call</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Wirescience

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

<a href="https://news.google.com/rss/articles/CBMi6AFBVV95cUxQQzZxeHBERnlZdUhnT1FFTTNodEFGNmM3My1KM3BiRm1NVzAyM1N5YTdzeXpvX09vMFJWb1ctREhxaUpydm1pTXVSLS1Pb0J4bUJzeng3T0VlbGZoUkFDVzdCWUZTQmNaaHB1TmRMeG9KdHkyOXV1M1R4MXR1UU5lN0plQmZGSW0td1pFYzE2TktmRkNSQlVERWVkYUdwcjlYV3Bhb1laZndIcUJNbFlDcFZ5WXlHaWpBMl9Eb2xuY0s5emJHa2F6a0dTSkpYTFZLR3lJNHEtWjJmMXZjMjAxeDBhNFp2X1M2?oc=5" target="_blank">Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections
Business Wirescience

Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections

<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxNcURDTE1XaVJyNlVYblRaeFY4TFBmdWhvaVFrV2ZzYTRvdGNBaEtrX19iTlp0RE5mWnZocVR0bklSV2RVdkhNdDBiaEdmYWhHb01LQ1RidTJCNzV1MDNyM2ZRbXlZX0hIZmlUczNVRXhmWjR1YWk3ZUF4X2xURTBJSTNHOU9Uc282MmNPSkppZElXN3dJRGNVZjFoQldfX2d1cHBrTnhRX09rR01OemE3cGE3NTdva2J6UGJ3Y0xGQ3lfMzljanB5RTdYcjJIa3RnUzNTUzEydURpdU93bHRZWW8tQjZwLW1jekNWREZ3S1NvXzBCUHJIY3U1MmkyUXhrU2N6S3h3?oc=5" target="_blank">Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Index Expanding Market Visibility with Institutional Investors
Business Wiremarkets

Index Expanding Market Visibility with Institutional Investors

<a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxOV1RvSUo4S1pGSHk3ZlFpNEFWTGs1QVNPWnlLclY5MHFxQkJBUlVadjllb1g0OVh4enhXWVJwSEF4RGhOYUkxY2dfWW5wX19fNUMzM054ZHJOWi1VdG5zZHdxZDFvV3lNYjdEMm80LUM3T2RzLVgwTlltQzVxbFRqckRvSFNEbjFtbHk3aXp6THgtWkxRdlBJS0xFdVVLMUh5dGdrZzNoOGtUc2w4bUx6RTdOWTd4SDNHYW90RExlT2lRRHJpTjlSMkMyVkVDSEVrbG5uTzRkN1VSVzVDaFpBN25UcHB2RDRKcVVZX2RjVWdQWjJTb19SNGRQWXRvZDEzUmFkQmpwMmtsVkNsTFE?oc=5" target="_blank">Index Expanding Market Visibility with Institutional Investors</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Business Wirescience

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxNdDlmSGRZQUZwTWxrVkJUd20yS2F3NjE3UHFLV1dLRk8tc0doSk9QeWxIUHdBYjFFX09zNFBlNmp1UHNGNTRfQkdIcHM1MTFrTGoxc2pmNG0zVUdnc1dMc3RkRmJ2NWZYdGtyODFTU1Q0cG03cEtHWjhBQWx1UzFPTU94RjVZaG1ZRlB1OUdKb3RZTEMtUTdXdGRoSk9ZeE1kYlVpejRwbk95WFBVR3g4ZmxlOGdGVm55VXBFazJYRnN6VEl5QTRVY3EtOWNOOV9hNTZCcWZzcF9Wekt0WlJyY3lR?oc=5" target="_blank">Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026
Business Wirescience

Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026

<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxOOEFDWXFISUd2QlZyWW5ucHMtZFIxbHgxWkFUWEV0NmNsMUpIakFta29vWmhJYkY5aFdxTlpSX1NZLTM4bGlsYXROckZQQjlFc0dBSWFjSFl2T19NTmRlUXNQamFwN29TanU5TkZLUS1DUHQzdXdQS0RMUU5KVUFCUlJRWmxaYWdTeXlZc2hnN3FLMkJQOHpSSnFpVFdPRV9OWnFtdmJsbGVkbF9Wd2dTQUxWUVlERktPU19Sa05JMXFOdTdPQ2RaZUtfZmhSNnp2OTRnUHBqVkpRQ3FmMkRlN0tiLW1qSlEtQ1hvbm81bmVYY19wYzJMb212RQ?oc=5" target="_blank">Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Precision begins patient enrolment for FUNCTION-DMD trial
Clinical Trials Arenaworld

Precision begins patient enrolment for FUNCTION-DMD trial

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOZVp5ZndMYWZaaWF5cXgyOXpaVENZcmxNVnp1c1RjbTZicnBfNjF5QVR3M0tybF9VVHIwNTVkQ0g3Zk8xNmx3YXBUUHl1Sl9uLXZhQnNaSWg1N054M19zU25EMG14YTBlanBfOU8xTGZucWdlRlNfYVpSUTdUS3N1VFltME5jWHlvaVhWcjVwblJudw?oc=5" target="_blank">Precision begins patient enrolment for FUNCTION-DMD trial</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
Precision BioSciences (DTIL) Stock Price, News & Analysis
Stock Titanmarkets

Precision BioSciences (DTIL) Stock Price, News & Analysis

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFBSaFlfRW12U1dsdXBCYjJ0U0ZiaGJBbV83d3NRSUowci1uZWt4eGMycWQzVTVpeEg0V290WFRVYVJFcXgxSnh1X1BrdVBybWlWYXpn?oc=5" target="_blank">Precision BioSciences (DTIL) Stock Price, News & Analysis</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
BioSpacescience

Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy

<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxObWtyR2hZTVNvY0lwSkYzWjd0TkRKZmFQTnRwZzFwRWdyaG5HQlhIRTkyTnN2SzRRTDNidkhGRkJwMktrcEg5Tzl2eEE3ZVhzb2dobk1ydkRBMFFPdkpmUWdCaTY4U1VBY1QyTFp6WXJNZERzSjZLQ0VGT2pjVUlhb1MtRmRURExYNnVLdnUxYXV2LUFYaVc1ZktqOWxOYnpsRnRDbXRmTFN4eWxJMGI2U2Y0a2h0M01Jek1QVUpPbE9sX3ZJRENtOTRXWjZwam9XbnQ1Smx1eGYtQi0zNWpEcl9GQjYwaERsOTI2QnJ6aUREM05sUE9fMUVpVmF0WjNzYjZv?oc=5" target="_blank">Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades
Simply Wall Streetmarkets

Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxNWU9PX0ZoNEUtV2pSaVhwU3dESDM4Zm1aYS1RNEVOSzd3YkNmaXBKMTBUbzJyX0ppeE1MYWk2bFktNlpVM1h6eHFKcGZtYXRmNTdpZkowTEJCVlZHa05US3pJRGJGMGEwSng4SnZOc1VtTkdNTnNnLUgyQldyaEVBYVpEal9BMFZkNzl4M0dPTWxlbHc0NUhVNVJMeTFkUjJsMWtoeVVQTWxvT0FEZmt1bFdPN0NFZ05PVkpCQ0llb2lFYkpNMXp3SmdwN290bS1EYktZNFV6WmNaSk9fTFVmaXcyYy1RQlZUeS1j0gHwAUFVX3lxTE5SSjFwbVJUMUhFSVQ3X3B6NGdiTjB0ZC1XTnlHV3ZtejloZGJoeG00WFRlNGNRckhXLXJKUEtMUDQyTkd6Q3pBM1pKODduTGV0SU5HT1YxNmxpb0pnUHdvbG1lRk5TSEwzWUY0cV9KMmtfWWVVVkhQMjkwTm5hZzFSTDdWWG1mVUR3c1lyalpXZEhMeDVPZ0pzNXdiQkpyQjd3NVAwVE5OclF3MFdfd0V5b0k1aUpwUl95Z3hka3RwcTBCb2p3MURUeldiOVBZakVBLUJXUnRaUjVOMjc4RHk5al9wQmpkc1Q1bWdQTGZraQ?oc=5" target="_blank">Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades</a>  <font color="#6f6f6f">Simply Wall Street</font>

Read Full StoryMore like this
Novartis plots Precision attack on sickle cell, paying $75M and putting up $1.4B in biobucks to form in vivo gene editing pact
Fierce Biotechgeneral

Novartis plots Precision attack on sickle cell, paying $75M and putting up $1.4B in biobucks to form in vivo gene editing pact

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOZ0tGNWJRSVhqd002SF9yTXdoakRJTE8zWGp4NGdOZVVnalQxSTFacUx0bHFlaHJMRzlKYWRiZVdSWjZfM2U2RXl3ZngtNmYtbElpSTI0TklXcDUxZ1ZaZnNIQ0lZdnltZ3hLeEFTaUktV1NfU0Z4N3NReXRobGk4cW12TXpNaEk0MEFtenRpbUFuMlprbUxDMm9OV1lodEZLUXJnS1p3aWVGcUNILTVQNDZlMnl0ZUlfWEVtTjFBUnRfaUV5dXc?oc=5" target="_blank">Novartis plots Precision attack on sickle cell, paying $75M and putting up $1.4B in biobucks to form in vivo gene editing pact</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Lilly's Prevail revises $2.6B biobucks deal with Precision to take on more preclinical work
Fierce Biotechtech

Lilly's Prevail revises $2.6B biobucks deal with Precision to take on more preclinical work

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPMFN0eDNOa1lIdEZKTmYycjRQZW5IemE1UUEzVDNMbFE5U2tybi05WjdDcUNCREU2MHdLSmtSdDVlU3I0UzhHXzdBOXFycGZFc2NlVTAzWDhxWHVHMVBBSUVydDUwamhpODd6eE02YUdPX3pnbVJRT2thRk9MRHlvT3VTcS03X1hsUVhxQmxyVS1DbnhIYnlrN3lfcWdUeGlZOEhQdjJOalVVLVpsaEdFbVJqamxFWlNIWWtEcWpkT2tzbHZUcUtxeA?oc=5" target="_blank">Lilly's Prevail revises $2.6B biobucks deal with Precision to take on more preclinical work</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Paving the way to equitable healthcare with lipid nanoparticles
Naturescience

Paving the way to equitable healthcare with lipid nanoparticles

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9TOWpTOXZfVlNwTndXMkp3V3JyUkg4d1J4bHkzVWs1YTBIczYyOG5sYmxROGNxekRYS1dkSUpSalI0UUNublRfNGhrU2dpNGdIcktJanRsT2xVbzNSOThn?oc=5" target="_blank">Paving the way to equitable healthcare with lipid nanoparticles</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Precision BioSciences to Present Late-Breaking Poster on PBGENE-HBV Gene-Editing Therapy at EASL Congress 2026
GeneOnlinescience

Precision BioSciences to Present Late-Breaking Poster on PBGENE-HBV Gene-Editing Therapy at EASL Congress 2026

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNT1U3bFpNTFE3Z2s5TFplTWVQR2hSNFlRaHVsS0E5SUNnZ1NFUE1qdW92NkFaQ1dGX0NvOG1XbnltUkJPb3NXcjdyZG9vbHhteFFZZGM2QmdDaHRuMTF3ckhsVUh3dG90dVhhcTlGZTktVnpqSFZxdDRmM1pmUWNkMHh0VU0yWGZxUmtIdGkwV01LZDRPRTJYZENQa1E4N2puY3ZwNGdtQkhscGlBa3RTZlY5NWliTUxiSlFLMllPaXB1NDZOOEhHVDlMZzIzRkc3a1A0dw?oc=5" target="_blank">Precision BioSciences to Present Late-Breaking Poster on PBGENE-HBV Gene-Editing Therapy at EASL Congress 2026</a>  <font color="#6f6f6f">GeneOnline</font>

Read Full StoryMore like this
Matt Kane steered his last biotech to an IPO. He’s back with a new startup and $40M
Raleigh News & Observertech

Matt Kane steered his last biotech to an IPO. He’s back with a new startup and $40M

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9XSGZTRnNqR3pIbGs5NTJVNS1tLUx1cG1nczNVLWlBQTdOMW9WSmJ3MFE5S2RzWGFOYjc3Mkd2cHRfRm5XLXlaYlI2enZMLUNXOGp2Zk5ScWJMRWthaWhRUTRveWc2SHpmRzdWVmdjQ0VsZ9IBckFVX3lxTFBfRlNUWXJaSTdaQ3Jiak4yOXVQb2FMMlZmVV8wbDAwRDJPelQtUkNDM2FUYkN2VnJKcjZwcGxkWHhMbVJ0YWpQVDNJSDBtSXpQV0xSQy1rbm9IVUlTVFZ0SEs5cVNJaGNMUmJOM1RhdVRqUQ?oc=5" target="_blank">Matt Kane steered his last biotech to an IPO. He’s back with a new startup and $40M</a>  <font color="#6f6f6f">Raleigh News & Observer</font>

Read Full StoryMore like this
Synthetic promoters enhance gene therapy precision
Drug Target Reviewgeneral

Synthetic promoters enhance gene therapy precision

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQeDBVRmd4cmRhWmRzLUZnelJvdjkwUmR1NllMRTZTMnFJSXNUcVZnOXFSYXdNZFBnZXBreml3dERLTngwb0g5ZG9JWFFXUkRqX2Z3Ry0wWWFGS0RpcEdzTkhhUE9RbVNrMXRJZ1VnMnJULUxOZlBlZng5R20teHp1MjJSNmJhenliVkZTTzhzb3pXRm5wamVkazVoa2YwU0E?oc=5" target="_blank">Synthetic promoters enhance gene therapy precision</a>  <font color="#6f6f6f">Drug Target Review</font>

Read Full StoryMore like this
Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS
Multiple Sclerosis News Todaygeneral

Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxPOV9kbjFxNkVfUTFQR211dVhGN25hUkFDd05PLUQyaTBxTTQxZ1RzYndoSFdFUlR5ZWltZTYzZ1RfZ0EtVmZQMDJLNVJETnVGVlFQQW1LX0dPNUlUVjk0cTdHQWotSFFDT3kyRnpURWN0cUR0Rl9mM3QxYTVwSFYxcEY3TEtIeXJSa0JZbmJXVkdHM2Z6ckp6Wm04X29qdjM0cS02VVVQdWNBeEo3cnVoMzZjWGxfUzdydzZtYmE2S18xM0VQ?oc=5" target="_blank">Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
"Precision BioSciences Set" — Live Google News Trends & Headlines